446 related articles for article (PubMed ID: 26289791)
1. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
2. Investigational new drugs for brain cancer.
Staedtke V; Bai RY; Laterra J
Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era.
Uhm JH; Porter AB
Mayo Clin Proc; 2017 Jun; 92(6):995-1004. PubMed ID: 28578786
[TBL] [Abstract][Full Text] [Related]
4. Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens.
Batich KA; Sampson JH
Expert Opin Pharmacother; 2014 Oct; 15(14):2047-61. PubMed ID: 25139628
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches to glioma drug design and drug screening.
Patil SA; Hosni-Ahmed A; Jones TS; Patil R; Pfeffer LM; Miller DD
Expert Opin Drug Discov; 2013 Sep; 8(9):1135-51. PubMed ID: 23738794
[TBL] [Abstract][Full Text] [Related]
7. Emerging patents in the therapeutic areas of glioma and glioblastoma.
Harris M; Svensson F; Kopanitsa L; Ladds G; Bailey D
Expert Opin Ther Pat; 2018 Jul; 28(7):573-590. PubMed ID: 29950117
[TBL] [Abstract][Full Text] [Related]
8. Emerging targeted therapies for glioma.
Miller JJ; Wen PY
Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
[TBL] [Abstract][Full Text] [Related]
9. Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
Zhang X; Zhang W; Mao XG; Cao WD; Zhen HN; Hu SJ
Curr Cancer Drug Targets; 2019; 19(2):101-108. PubMed ID: 29848277
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of gliomas: potential therapeutic implications.
Alentorn A; Duran-Peña A; Pingle SC; Piccioni DE; Idbaih A; Kesari S
Expert Rev Anticancer Ther; 2015; 15(8):955-62. PubMed ID: 26118895
[TBL] [Abstract][Full Text] [Related]
11. Single vs. combination immunotherapeutic strategies for glioma.
Chandran M; Candolfi M; Shah D; Mineharu Y; Yadav VN; Koschmann C; Asad AS; Lowenstein PR; Castro MG
Expert Opin Biol Ther; 2017 May; 17(5):543-554. PubMed ID: 28286975
[TBL] [Abstract][Full Text] [Related]
12. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
Yu JS; Luptrawan A; Black KL; Liu G
Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
[TBL] [Abstract][Full Text] [Related]
13. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract][Full Text] [Related]
15. Glioma-specific antigens for immune tumor therapy.
Skog J
Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for glioma: from illusion to realistic prospects?
Dietrich PY; Dutoit V; Walker PR
Am Soc Clin Oncol Educ Book; 2014; ():51-9. PubMed ID: 24857060
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutics for brain tumors: current practice and future prospects.
El Demerdash N; Kedda J; Ram N; Brem H; Tyler B
Expert Opin Drug Deliv; 2020 Jan; 17(1):9-21. PubMed ID: 31971041
[No Abstract] [Full Text] [Related]
18. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
[TBL] [Abstract][Full Text] [Related]
19. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
Sonabend AM; Dana K; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
[TBL] [Abstract][Full Text] [Related]
20. Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins.
Loya J; Zhang C; Cox E; Achrol AS; Kesari S
CNS Oncol; 2019 Nov; 8(3):CNS38. PubMed ID: 31747788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
